Genomic Testing Cooperative

Genomic Testing Cooperative State-of-the-art Innovation
Machine/deep Learning meets Next Generation Sequencing

GTC is excited to be exhibiting at the USCLC Annual Workshop—a leading forum advancing care in cutaneous lymphomas. Stop...
03/23/2026

GTC is excited to be exhibiting at the USCLC Annual Workshop—a leading forum advancing care in cutaneous lymphomas. Stop by to learn how GTC is uniquely equipped to support skin-based diagnostics, including challenging cases of cutaneous T-cell lymphoma (CTCL).
Our comprehensive DNA + RNA profiling enables deeper insights into disease classification, clonality, and actionable alterations, even from limited or difficult skin samples.
https://genomictestingcooperative.com/genomic-tests/gtc-hematology-profile-plus/

Catch the GTC Team at the Iowa Hematology & Oncology Conference 2026 today March 21 in Des Moines.Come learn more about ...
03/21/2026

Catch the GTC Team at the Iowa Hematology & Oncology Conference 2026 today March 21 in Des Moines.

Come learn more about our our comprehensive DNA and RNA profiling across tissue, blood, and bone marrow that help clinicians:
• Detect actionable alterations
• Identify resistance mechanisms earlier
• Inform targeted therapy decisions across hematologic malignancies and solid tumors

Kidney cancer, including renal cell carcinoma, is a complex disease where deeper molecular insight can help inform treat...
03/20/2026

Kidney cancer, including renal cell carcinoma, is a complex disease where deeper molecular insight can help inform treatment strategies and identify emerging therapeutic opportunities. As precision oncology evolves, comprehensive genomic profiling is playing an increasingly important role in guiding care.

At Genomic Testing Cooperative (GTC), our testing analyzes both DNA and RNA, enabling detection of mutations, gene fusions, and other clinically relevant alterations that may not be captured with DNA-only approaches. By delivering a more complete molecular profile, we help clinicians make more informed decisions for patients with kidney cancer.

Learn More: https://genomictestingcooperative.com/genomic-tests/solid-tumor-profile-plus/

Join us at the Hematologic Malignancies Symposium & Genomics Workshop (May 7–8, Tampa, FL) and hear from Dr. Maher Albit...
03/19/2026

Join us at the Hematologic Malignancies Symposium & Genomics Workshop (May 7–8, Tampa, FL) and hear from Dr. Maher Albitar, CEO/CMO of Genomic Testing Cooperative, as he shares insights on the evolving role of molecular diagnostics and AI in hematologic cancers.

Register now to secure your spot in Tampa: https://www.hememalignanciessymposium.com/

We’re excited to help lead the Neuro-Oncology Track at the Society for Brain Mapping and Therapeutics 23rd Annual NeuroT...
03/17/2026

We’re excited to help lead the Neuro-Oncology Track at the Society for Brain Mapping and Therapeutics 23rd Annual NeuroTech Convention, taking place April 16–19, 2026 at the Los Angeles Convention Center.

Our session, “Updates in Brain Metastasis and Leptomeningeal Disease: Medical Management,” will feature leading experts discussing advances in detection, therapy resistance, and molecular insights shaping the future of CNS oncology.

🎤 Including a presentation from Maher Albitar, MD on interpreting molecular changes in metastatic tumors using cfDNA/RNA.

Learn more about the meeting:
https://www.worldbrainmapping.org/sbmt-2026

Limited tissue should not limit clinical insight. GTC is optimized to deliver comprehensive solid tumor profiling from v...
03/16/2026

Limited tissue should not limit clinical insight. GTC is optimized to deliver comprehensive solid tumor profiling from very small quantities of tissue, including scant samples with as little as 6-8 slides.

Our advanced NGS workflows are designed to maximize yield from low-input specimens, enabling:

- Parallel DNA and RNA sequencing from minimal tissue
-Detection of mutations, copy number changes, and gene fusions
-Gene expression and immune profiling to support therapy selection
-Preservation of tissues for future testing or clinical needs

https://genomictestingcooperative.com/genomic-tests/solid-tumor-profile-plus/

A reminder that comprehensive testing can meaningfully impact patient outcomes.Molecular profiling that evaluates both D...
03/13/2026

A reminder that comprehensive testing can meaningfully impact patient outcomes.
Molecular profiling that evaluates both DNA and RNA is essential in colorectal cancer. DNA analysis identifies key genomic alterations, while RNA analysis reveals gene fusions, splice variants, and expression changes that may be missed otherwise—together providing a more complete picture to support diagnosis, prognosis, and therapy selection.
Equally important is DPYD genotyping, which helps identify patients at increased risk for severe toxicity from fluoropyrimidine-based therapies. Incorporating DPYD testing upfront can support safer treatment planning and more personalized c

https://genomictestingcooperative.com/genomic-tests/solid-tumor-profile-plus/

GTC specializes in challenging cases. Consider sending cases to us when:• You are diagnosing rare tumor types• Patients ...
03/10/2026

GTC specializes in challenging cases. Consider sending cases to us when:

• You are diagnosing rare tumor types
• Patients are not responding to therapy
• You are working with limited tissue

GTC's Multiple Myeloma testing integrates targeted DNA and RNA sequencing to deliver comprehensive molecular profiling t...
03/09/2026

GTC's Multiple Myeloma testing integrates targeted DNA and RNA sequencing to deliver comprehensive molecular profiling that aligns with consensus guideline markers. By performing CD138+ enrichment on fresh bone marrow specimens, we increase sensitivity and provide deeper insight into tumor biology—including copy number variants (CNVs), prognostic RNA expression (e.g., CCND1, MAF, MYC, NSD2), and TP53 alterations. GTC’s approach offers clinicians robust diagnostic data to optimize evaluation, classification, and risk stratification.

Learn more: https://genomictestingcooperative.com/genomic-tests/

Address

25371 Commercentre Drive
Lake Forest, CA
92630

Telephone

+19495409421

Website

Alerts

Be the first to know and let us send you an email when Genomic Testing Cooperative posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Genomic Testing Cooperative:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category